Highlights

  • Eden reported a further AUD 475,000 South American order for EdenCrete Pz7 in October.
  • The company outlined a growing US-based project pipeline for EdenCrete in late October.
  • Eden reported a 152% rise in US Revenue for the first quarter of FY2027.
  • Eden continued Marketing its concrete additive products and reporting commercial trial activities.

Eden Innovations Limited (ASX:EDE) placed its EdenCrete concrete admixture Business at the centre of its October 2026 updates, reporting both additional product orders and progress in a US project pipeline. Its late-October South American announcement described a further AUD 475,000 order for EdenCrete Pz7, while separate reports addressed commercial interest and US sales. These are different forms of progress: an order documents a customer commitment, while a project pipeline covers prospective future activity.

South American Order Adds to Commercial Activity

On 29 October, Eden announced another South American purchase order valued at AUD 475,000 for its EdenCrete Pz7 product. The company’s EdenCrete range is designed for applications involving concrete performance. Eden’s business involves Manufacturing and selling additive technology rather than exploring for or producing oil and gas. As such, customer orders, delivered products, trials and repeat sales are central metrics for assessing its commercialisation strategy.

US Revenue and Project Prospects Provide Context

The company’s 6 October sales update reported US Subsidiary revenue of US$381,612 in the first quarter of FY2027, a 152% increase from the corresponding period. A later October release described the expanding US-based project pipeline. Pipeline projects must be kept separate from revenue already recognised. Eden has also reported concrete product trial work in India during 2026, showing that its commercial efforts span multiple geographic markets.

Outlook: Convert Projects Into Recurring Sales

The next important steps are product deliveries, repeat orders and conversion of trials and prospective projects into paying customers. Management continues to promote EdenCrete products in the United States and international markets. Reported first-quarter growth reflects one specified period and is not a full-year result or a guarantee of a repeat growth rate. Further sales updates and regular cash-flow statements will show how commercial activity develops.

Eden Innovations shares traded at AUD 0.051 on 6 November 2026, with a reported daily change of 0.00%. Trading Volume was 241,273 shares, and the day’s high and low were AUD 0.054 and AUD 0.051. Market Capitalisation was approximately AUD 32.23 million.